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ABSTRACT
Background: Clinical effects, recovery characteristics, and costs of total intra- 
venous anesthesia with different inhalational anesthetics have been investigated 
and compared; however, there are no reported clinical studies focusing on the ef-
fects of anesthesia with propofol and desflurane in patients undergoing laparo-
scopic cholecystectomy.
Objective: The aim of this study was to determine the effects of total intrave-
nous anesthesia with propofol and alfentanil compared with those of desflurane and 
alfentanil on recovery characteristics, postoperative nausea and vomiting (PONV), 
duration of hospitalization, and gastrointestinal motility.
Methods: Patients classified as American Society of Anesthesiologists physical 
status I or II undergoing elective laparoscopic cholecystectomy due to benign gall-
bladder disease were enrolled in the study. Patients were randomly assigned at a 
1:1 ratio to receive total intravenous anesthesia with propofol (2–2.5 mg/kg) and 
alfentanil (20 μg/kg) or desflurane (4%–6%) and alfentanil (20 μg/kg). Perioperative 
management during premedication, intraoperative analgesia, relaxation, ventilation, 
and postoperative analgesia were carried out identically in the 2 groups. Extubation 
time, recovery time, PONV, postoperative antiemetic requirement, time to gastroin-
testinal motility and flatus, duration of hospitalization, and adverse effects were re-
corded. Postoperative pain was assessed using a visual analogue scale.
Results: Sixty-eight patients were assessed for inclusion in the study; 5 were 
excluded because they chose open surgery and 3 did not complete the study because 
they left the hospital. Sixty patients (33 women, 27 men) completed the study. Re-
covery time was significantly shorter in the propofol group (n = 30) compared with 
the desflurane group (n = 30) (8.0 [0.77] vs 9.2 [0.66] min, respectively; P < 0.005). 
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Fifteen patients (50.0%) in the propofol group and 20 patients (66.7%) in the 
desflurane group experienced nausea during the first 24 hours after surgery. The differ-
ence was not considered significant. In the propofol group, significantly fewer pa-
tients had vomiting episodes compared with those in the desflurane group (2 [6.7%] 
vs 16 [53.3%]; P < 0.005). Significantly fewer patients in the propofol group required 
analgesic medication in the first 24 hours after surgery compared with those in the 
desflurane group (10 [33.3%] vs 15 [50.0%]; P < 0.005). Patients in the propofol 
group experienced bowel movements in a significantly shorter period of time compared 
with patients in the desflurane group (8.30 [1.67] vs 9.76 [1.88] hours; P = 0.02). The 
mean time to flatus occurred significantly sooner after surgery in the propofol group 
than in the desflurane group (8.70 [1.79] vs 9.46 [2.09] hours; P = 0.01). The duration 
of hospitalization after surgery was significantly shorter in the propofol group than in 
the desflurane group (40.60 [3.49] vs 43.60 [3.56] hours; P = 0.03).
Conclusion: Total intravenous anesthesia with propofol and alfentanil was 
associated with a significantly reduced rate of PONV and analgesic consumption, 
shortened recovery time and duration of hospitalization, accelerated onset of bowel 
movements, and increased patient satisfaction compared with desflurane and alfentanil 
in these patients undergoing laparoscopic surgery who completed the study. (Curr 
Ther Res Clin Exp. 2009;70:94–103) © 2009 Excerpta Medica Inc.
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INTRODUCTION
Laparoscopic cholecystectomy is usually associated with a short period of hospitaliza-
tion; however, postoperative nausea and vomiting (PONV) and the late onset of bowel 
movements are the most common reasons for prolonged hospitalization, especially after 
laparoscopic surgeries.1–3 Patient satisfaction is reduced because of these factors.
Anesthetic techniques that reduce these adverse effects (AEs) are essential for 
laparoscopic interventions. Total intravenous anesthesia with propofol and alfenta-
nil is increasingly used in same-day surgery because of its suggested beneficial 
effects on recovery time, PONV, and pain.1,3 Six studies have indicated that propo-
fol and alfentanil were associated with reduced PONV, duration of hospitalization, 
and recovery time1–6; however, most of the data were obtained from studies per-
formed on nonselected patients. The few studies of patients undergoing laparoscopic 
surgery suggested that propofol and alfentanil had no significant effects on gastro-
intestinal motility in the postoperative period.1,7,8 Factors other than the type of 
anesthesia may affect motility after laparoscopic cholecystectomy.3,5,6 A meta-analysis 
found that there was insufficient evidence to conclude that propofol and alfentanil 
reduced PONV.8–11
This study was conducted to investigate the effects of propofol and alfentanil total 
intravenous anesthesia on PONV, recovery time, gastrointestinal motility, patient satis-
faction, and duration of hospitalization after laparoscopic cholecystectomy compared 
with the outcomes of patients administered desflurane and alfentanil anesthesia.
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PATIENTS AND METHODS
This study was approved by the Ethics Committee of Mustafa Kemal University, 
Antakya, Hatay, Turkey. Patients provided written informed consent before partici-
pating in the study.
All patients, classified by the American Society of Anesthesiologists as physical 
status I or II,12 undergoing elective laparoscopic cholecystectomy due to benign 
gallbladder disease were assessed for inclusion in the study. Patients were recruited for 
enrollment preoperatively on the day of surgery. 
Exclusion criteria were allergy to any of the medications used in the study, current 
symptoms of nausea or vomiting, or treatment with an antiemetic drug. Patients who 
chose open cholecystectomy were also excluded.
Demographic data, including age, weight, and history of PONV or motion sickness, 
were recorded. Patients were randomized into 2 groups using a computer-generated 
block-randomized number table. Randomization was performed by a statistical expert 
who was blinded to the study design. 
All patients were premedicated with IV midazolam 2 mg, 30 minutes before the 
induction of anesthesia. In the operating room, patients underwent routine monitoring, 
including blood pressure (BP), heart muscle electrical potential, oxygen saturation, 
and end-tidal carbon dioxide. To reduce the pain associated with propofol infusion, 
patients received IV 1% lidocaine 0.5 mg/kg. 
In the propofol group, anesthesia was induced with IV alfentanil 20 μg/kg and then 
propofol at 2 to 2.5 mg/kg was administered. To maintain anesthesia, propofol 
was initiated at 10 mg/kg/h and was reduced by 2 mg/kg/h every 10 minutes to 
6 mg/kg/h at which time alfentanil 0.5 μg/kg/min was administered with an intravenous 
infusion pump (Injectomat Agilia, Fresenius Kabi AG, Bad Homburg, Germany). In 
the group receiving desflurane, anesthesia was induced with propofol 2 to 2.5 mg/kg 
and alfentanil 20 μg/kg and maintained with desflurane 4% to 6% and IV alfentanil 
0.5 μg/kg/min. To avoid the possible effects of lidocaine on the findings, we adminis-
tered lidocaine to both groups. After sufficient anesthesia was achieved, muscle relaxa-
tion was achieved with IV rocuronium bromide 0.6 mg/kg. Endotracheal intubation 
was performed after 90 seconds in both groups. Both groups were mechanically ven-
tilated with 30% oxygen in air. End-tidal carbon dioxide was maintained between 
35 to 40 mm Hg in both groups. The depth of anesthesia was measured using the 
bispectral index score,4 and anesthesia was adjusted to obtain a score of 40 to 60 in both 
groups. Preoperative analgesia was provided with alfentanil infusion (0.5 μg/kg/min) 
and was stopped 30 minutes before the end of the procedure. Antiemetic prophylaxis 
was not administered to any patient. For each patient, a nasogastric tube was in place 
during anesthesia. At the end of surgery, anesthetic agents were stopped and neuro-
muscular blockade was reversed with IV neostigmine 1.5 mg and atropine 0.5 mg. 
The time of discontinuation of the anesthetic agents and the extubation time were 
recorded. The time at which each patient responded to verbal commands (recovery time) 
was recorded.
Postoperative analgesia was initially provided with titrated IM pethidine 5 mg/kg. 
Diclofenac sodium 75 mg was administered intramuscularly if the visual analog scale 
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(VAS) score for pain was >5. VAS was assessed with a 10-cm scale (0 = no pain to 
10 = unbearable pain). Total analgesic consumption was recorded for each patient. If 
PONV occurred, patients were administered orally prochlorperazine 10 mg.
Patients were blinded to randomization and staff in the postanesthesia care unit 
collecting the data were blinded to the study protocol. One anesthesiologist (Z.A.) 
provided anesthesia and another anesthesiologist, who was blinded, recorded the data 
after the induction of anesthesia.
The duration of hospitalization, pain score, and number of PONV episodes requir-
ing antiemetic treatment until the time of recovery were recorded. Assessments were 
recorded 15 minutes and 2, 6, 12, 24, 36, and 48 hours after surgery. Bowel move-
ments were auscultated, and the time of flatus was recorded. Patients were initiated 
on an oral diet regimen after the onset of bowel movements.
Forty-eight hours after surgery, the discharged patients were interviewed by tele-
phone and those who were still hospitalized were interviewed in the hospital to assess 
their satisfaction. Postdischarge nausea and vomiting were recorded. Postoperative 
nausea was recorded from the medical chart during the hospitalization process and 
after discharge through patient interview.
Satisfaction with the surgery as well as preoperative and postoperative anesthesia 
were assessed using a 3-point scale: 1 = not satisfied; 2 = satisfied; and 3 = completely 
satisfied.
AEs (eg, hypotension, allergic reactions, respiratory depression, agitation, or delirium) 
were recorded during surgery and hospitalization.
Statistical Analysis
We calculated that 20 patients per group were required to provide 80% power 
(β = 0.2) based on the intent to detect a reduction in the incidence of PONV, or the 
requirement for antiemetic treatment, from 60% with inhalational anesthesia with 
desflurane and alfentanil to 40% with propofol and alfentanil in the intent-to-treat 
population. The primary outcome was the incidence of complete response, defined as 
the absence of nausea and vomiting. The Mann-Whitney and χ2 tests were used for 
statistical analysis. P < 0.05 was considered statistically significant. Data were ex-
pressed as mean (SD). Statistical analyses were calculated using SPSS version 13.0 
(SPSS Inc., Chicago, Illinois).
RESULTS 
Sixty-eight patients were assessed for inclusion in the study; 3 were excluded because 
they chose open surgery and 5 did not complete the study because they left the hos-
pital in the first 12 hours postsurgery (n = 2, propofol group) or on day 1 for personal 
reasons (lack of insurance [n = 2], desflurane group; death in the family [n = 1], des-
flurane group). Therefore, 60 patients (33 women, 27 men) completed the study 
(Table I). There were no significant differences in patient characteristics, periopera-
tive management, or postoperative pain management between the propofol (n = 30) 
and the desflurane (n = 30) groups. Surgery and anesthesia administration were un-
eventful in all patients.
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Mean (SD) operating time and mean anesthesia time did not differ significant- 
ly between the 2 groups (Table I). Mean arterial BP was not significantly different; 
101.40 mm Hg (systolic/diastolic, 129/82 mm Hg) in the propofol group and 
109.70 mm Hg (126/94 mm Hg) in the desflurane group. Hypotension (defined as BP 
<90/60 mm Hg) occurred in significantly more patients in the propofol group than 
in the desflurane group (8 vs 1, respectively; P < 0.005). Three patients with hypo- 
tension in the propofol group recieved IV ephedrine 5 mg.
Mean time to extubation was significantly shorter in the propofol group than 
the desflurane group (6.40 [4.20] vs 7.60 [0.68] min, respectively; P < 0.05). 
Recovery time was significantly shorter in the propofol group than the desflurane 
group (8.00 [0.77] vs 9.20 [0.66] min; P < 0.05) (Table II).
Fifteen patients (50.0%) in the propofol group and 20 patients (66.7%) in the 
desflurane group had nausea during the first 24 hours after surgery, although the 
difference was not significant. The number of patients who required antiemetic treat-
ment in the first 24 hours after surgery was similar in the propofol group and the 
desflurane group (12 [40.0%] vs 16 [53.3%], respectively). Significantly fewer pa-
tients in the propofol group had vomiting episodes than in the desflurane group 
(2 [6.7%] vs 16 [53.3%]; P < 0.005). Significantly fewer patients in the propofol 
group required analgesic medication in the first 24 hours after surgery than in the 
desflurane group (10 [33.3%] vs 15 [50.0%]; P < 0.005). 
The mean (SD) VAS score for pain in the propofol group was significantly lower at 
15 minutes compared with the desflurane group (2.96 [0.71] vs 4.63 [1.03] min, 
respectively; P = 0.01) and at 1 hour after surgery (4.13 [1.50] vs 5.70 [0.67]; P < 
0.01). Two patients (6.7%) in the propofol group and 8 patients (26.7%) in the des-
flurane group required analgesic treatment as rescue medication during the first 
6 hours after surgery. After 6 hours, none of the patients in either group required 
antiemetic medication or analgesic treatment.
Patients in the propofol group had bowel movements significantly earlier than 
patients in the desflurane group (8.30 [1.67] vs 9.76 [1.88] hours, respectively; P = 
Table I. Demographic and clinical characteristics of the study patients (N = 60).* 
 Propofol Group Desflurane Group 
Characteristic (n = 30) (n = 30)
Age, mean (SD), y 55.1 (8.8) 56.2 (12.6)
Sex, no. (%)
  Female 17 (56.7) 16 (53.3)
  Male 13 (43.3) 14 (46.7)
Weight, mean (SD), kg 72.1 (5.9) 72.0 (9.7)
ASA I/II 18/12 20/10
Operating time, mean (SD), min 78.4 (7.1) 80.7 (10.0)
Anesthesia time, mean (SD), min 91.3 (5.5) 91.0 (9.3)
ASA = American Society of Anesthesiologists.
*No significant between-group differences were found.
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0.02); therefore, an oral diet was resumed earlier in the propofol group. Flatus occurred 
significantly sooner after surgery in the propofol group compared with the desflurane 
group (8.70 [1.79] vs 9.46 [2.09] hours; P = 0.01). The duration of hospitalization after 
surgery was significantly shorter in the propofol group than in the desflurane group 
(40.60 [3.49] vs 43.60 [3.56] hours; P = 0.03) (Table III). No patient in either group 
remained hospitalized >48 hours after surgery because of prolonged nausea and vomit-
ing. One patient (3.3%) in the propofol group and 3 patients (10.0%) in the desflurane 
group were readmitted to the hospital because of nausea.
One patient (3.3%) in the propofol group and 4 patients (13.3%) in the desflurane 
group were not satisfied with the surgery (P < 0.001). Twenty-two patients (73.3%) 
in the propofol group and 26 patients (86.7%) in the desflurane group were satisfied 
with the surgery. Seven patients (23.3%) in the propofol group and none in the desflu-
rane group were completely satisfied with the surgery (P < 0.01).
Table II.  Recovery characteristics by treatment group in these patients receiving total 
intravenous anesthesia with propofol versus inhalation anesthesia with desflu-
rane for laparoscopic cholecystectomy (N = 60). Data are mean (SD).
 Propofol Group Desflurane Group 
Characteristic  (n = 30)  (n = 30)
Time to extubation, min* 6.40 (4.20) 7.60 (0.68)
Recovery time, min* 8.00 (0.77) 9.20 (0.66)
Pain VAS† at 15 min‡ 2.96 (0.71) 4.63 (1.03)
Pain VAS† at 60 min§ 4.13 (1.50) 5.70 (0.67)
VAS = visual analog scale.
*P < 0.05.
†Scale: 0 = no pain to 10 = unbearable pain.
‡P = 0.01.
§P < 0.01.
Table III.  Time to the start of bowel movements, mobilization, and flatus, and duration 
of hospitalization after surgery in these patients receiving total intravenous 
anesthesia with propofol versus inhalation anesthesia with desflurane for lap-
aroscopic cholecystectomy (N = 60). Data are mean (SD).
 Propofol Group Desflurane Group 
Characteristic (n = 30) (n = 30) P
Time to onset of  
bowel movements, h 8.30 (1.67) 9.76 (1.88) 0.02*
Time to mobilization, h 9.40 (1.79) 11.10 (2.02) 0.25
Time to flatus, h 8.70 (1.79) 9.46 (2.09) 0.01*
Duration of hospitalization, h 40.60 (3.49) 43.60 (3.56) 0.03*
*P < 0.05.
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Respiratory depression or agitation was not reported by any of the patients. 
Although 2 patients had diarrhea on day 1 and 3 patients had rectal bleeding on day 2, 
no patients reported headache or lumbar pain.
DISCUSSION
The present study found that total intravenous anesthesia with propofol and alfentanil 
was associated with significantly reduced PONV and analgesic consumption, short-
ened recovery time and duration of hospitalization, and accelerated bowel movements 
in these patients undergoing laparoscopic surgery who completed the study when 
compared with anesthesia with desflurane and alfentanil. The rate of patient satisfac-
tion was significantly higher in the propofol group than in the desflurane group.
During surgery, anesthesia was uneventful with both anesthethic techniques. How-
ever, systolic and diastolic BP were significantly more stable in the desflurane group. 
This finding is consistent with the findings of Ozkose et al13 and Smith and Thwaites.14 
Hypotension after propofol anesthesia is an expected event and the incidence has been 
reported to be between 10% and 55%.13,15–17
PONV has been the most common cause of prolonged hospitalization after same-
day surgery, and is experienced in 30% to 50% of the cases, especially after laparo-
scopic cholecystectomy.1 Unexpected readmission to the hospital because of uncon-
trolled PONV has led to substantial costs in terms of lost productivity for both 
patients and those caring for them.4 In the present study, significantly more patients 
in the desflurane group experienced PONV and required antiemetic drug treatment 
compared with the propofol group (P < 0.001). Paech et al1 reported that propofol 
and alfentanil, with or without dolasetron, was associated with significantly reduced 
PONV compared with inhalation anesthesia with sevoflurane in patients undergoing 
gynecologic laparoscopy. Raeder et al,18 in a study comparing desflurane and propofol 
anesthesia in patients undergoing laparoscopic surgery, reported that propofol anes-
thesia was associated with significantly less postoperative nausea (P < 0.001). Simi-
larly, Grundmann et al19 found that propofol resulted in significantly less postoperative 
analgesic consumption and nausea compared with desflurane. However, if propofol was 
substituted for volatile anesthetics, the risk for PONV was reduced by only ~20%.10 
Visser et al20 compared the effects of propofol with alfentanil and isoflurane with nitrous 
oxide anesthesia on PONV in unselected patients. It was reported that the propofol 
and alfentanil combination was associated with a clinically relevant reduction of 
PONV, and both anesthetic techniques were similar otherwise. Juckenhöfel et al21 
investigated the effect of propofol and alfentanil, and balanced anesthesia with 
sevoflurane in laparoscopic surgery. No significant between-group difference in shiv-
ering or PONV was reported. In the present study, we compared desflurane anesthesia 
with propofol and alfentanil and found a significantly reduced incidence of PONV. 
Desflurane’s AEs and pharmacologic characteristics are similar to those of isoflurane.
The delayed onset of bowel movements may cause patient discomfort and delayed 
discharge from the hospital. Walldén et al7 studied the effect of anesthetic technique 
on early postoperative gastric emptying using the acetaminophen method. Aceta-
minophen (paracetamol) is not absorbed from the stomach but is rapidly absorbed 
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from the small intestine; therefore, the rate of gastric emptying determines the rate 
of absorption of acetaminophen administered into the stomach. Acetaminophen 1.5 g 
was administered through a nasogastric tube, and blood samples were drawn during 
a 2-hour period. It was found that early gastric emptying with inhalation anesthesia 
was similar to that with propofol anesthesia. Gastric emptying was delayed in varying 
ranges with both anesthetic techniques. Liao et al22 investigated the effect of propofol 
and alfentanil anesthesia on gastrointestinal motility by measuring plasma motilin 
concentration after laparoscopic cholecystectomy and also did not find a significant 
influence of the anesthesia type on the recovery of intestinal motion. In the present 
study, we found that gastric motility recovered significantly earlier in the propofol 
group (P < 0.001). In contrast to previous studies, we used clinical assessment rather 
than laboratory methods to evaluate gastric motility. This may be the reason for the 
different findings.
The mean duration of hospitalization was significantly shorter and patient satisfac-
tion was significantly higher in the propofol group than in the desflurane group (both, 
P < 0.001). The subjective degree of patient satisfaction and the rate of satisfied pa-
tients were significantly higher in the propofol group than the desflurane group. 
These findings are consistent with previous studies.3–7,13,14 Although the improve-
ment in recovery time in the propofol group in contrast to the desflurane group may 
not be important clinically, we suggest that the other advantages (especially patient 
satisfaction) support the use of propofol and alfentanil in patients undergoing laparo-
scopic cholecystectomy.
Hypotension is a commonly expected AE associated with propofol and alfentanil; 
a variety of AEs, including convulsions, seizures, opisthotonos, involuntary muscle 
activities, and tonic-clonic movements, have been observed with propofol.19,21,22 Line 
infection due to intravenous cathetherization is another complication.21,22 Propofol 
infusion syndrome involves severe metabolic acidosis, rhabdomyolysis, renal failure, and 
cardiac failure in association with prolonged propofol infusion, critical illness, and 
concurrent administration of catecholamines and steroids.23 Although this condition 
is not expected with short-term infusion, caregivers should be aware of this possible 
complication because of the high mortality rate associated with it.
The major disadvantage of propofol and alfentanil, as reported in the current litera-
ture, is its cost.1,13,20,21,24,25 We did not assess the cost-effectiveness of propofol and 
alfentanil, which is a limitation of this study. Another limitation was the small size of 
the study groups. However, we believe that the lower consumption of antiemetic 
medications during hospitalization and in the postdischarge period, the shorter dura-
tion of hospitalization, and the lower rate of postdischarge readmission to the hospital 
in the propofol group should be considered benefits of propofol and alfentanil that 
help reduce the overall costs associated with laparscopic cholecystectomy.
CONCLUSION
Total intravenous anesthesia with propofol and alfentanil was associated with signifi-
cantly reduced PONV and analgesic consumption, shortened recovery time and duration 
of hospitalization, accelerated onset of bowel movements, and increased patient satis-
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faction without significant AEs compared with desflurane and alfentanil in these 
patients undergoing laparoscopic surgery who completed the study.
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